Accelerating Drug Development Panel Discussion

Accelerating Drug Development through the Convergence of Real-World Data

The convergence of real-world data (RWD), technology and artificial intelligence (AI) is playing a vital role in accelerating drug development. In a recent panel discussion at DIA Global, our experts explored how these elements are reshaping clinical research and drug discovery.

Some discussion highlights include

• Optimizing trial design and protocol development
• Use of AI across drug development phase
• Reduced costs

Watch the webinar to learn how partnering with a single CRO like the PPD^™ clinical research business of Thermo Fisher Scientific simplifies the process, ensuring consistency and efficiency in utilizing real-world data, technology and artificial intelligence.